161 related articles for article (PubMed ID: 35157100)
1. Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours.
Takácsi-Nagy Z; Ferenczi Ö; Major T; Akiyama H; Fröhlich G; Oberna F; Révész M; Poósz M; Polgár C
Strahlenther Onkol; 2022 Sep; 198(9):812-819. PubMed ID: 35157100
[TBL] [Abstract][Full Text] [Related]
2. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
[TBL] [Abstract][Full Text] [Related]
3. Results of postoperative interstitial brachytherapy of resectable floor of mouth tumors.
Ferenczi Ö; Major T; Akiyama H; Fröhlich G; Oberna F; Révész M; Poósz M; Polgár C; Takácsi-Nagy Z
Brachytherapy; 2021; 20(2):376-382. PubMed ID: 33250304
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of postoperative interstitial high-dose-rate brachytherapy and modern external beam radiotherapy modalities in tongue and floor of the mouth tumours in terms of doses to critical organs.
Ferenczi Ö; Major T; Fröhlich G; Béla D; Tódor S; Polgár C; Akiyama H; Bukovszky B; Takácsi-Nagy Z
Radiol Oncol; 2023 Dec; 57(4):516-523. PubMed ID: 38038418
[TBL] [Abstract][Full Text] [Related]
5. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
6. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
7. Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue.
Goineau A; Piot B; Malard O; Ferron C; Lisbona A; Cassagnau E; Delamazure AS; Campion L; Bardet E
Brachytherapy; 2015; 14(1):71-6. PubMed ID: 25454575
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer.
Takácsi-Nagy Z; Oberna F; Koltai P; Hitre E; Major T; Fodor J; Polgár C
Brachytherapy; 2013; 12(6):535-41. PubMed ID: 23988507
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy for early stage oral tongue cancer.
Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
[TBL] [Abstract][Full Text] [Related]
11. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy in early oral cancer with close or positive margins.
Petera J; Sirák I; Laco J; Kašaová L; Tuček L; Doležalová H
Brachytherapy; 2015; 14(1):77-83. PubMed ID: 25264037
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
14. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
15. Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients - Gliwice experience.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Składowski K; Szlag M; Cholewka A
J Contemp Brachytherapy; 2010 Jun; 2(2):61-63. PubMed ID: 27829846
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of high-dose-rate brachytherapy and perioperative brachytherapy in early mobile tongue cancer.
Potharaju M; E HR; Muthukumaran M; Venkataraman M; Ilangovan B; Kuppusamy S
J Contemp Brachytherapy; 2018 Feb; 10(1):64-72. PubMed ID: 29619058
[TBL] [Abstract][Full Text] [Related]
17. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
18. The impact of surgical margin status and use of an interstitial implant on T1, T2 oral tongue cancers after surgery.
Chao KS; Emami B; Akhileswaran R; Simpson J; Spector G; Sessions D
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1039-43. PubMed ID: 8985025
[TBL] [Abstract][Full Text] [Related]
19. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
